Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy VI: Nursing Management

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Friend and Confidant Thresholds: Social Network Size as a Mediator Between Marital Status and Major Depressive Disorder.

Depression and anxiety·2026

Same author

A Longitudinal Study on Predicting Treatment Response in Depression Using Self-Reported Symptoms.

Journal of Korean medical science·2026

Same author

Correction: Effectiveness of digital self-care device for at risk drinking problems: focus on individuals at risk for alcohol-related issues.

Frontiers in psychiatry·2026

Same author

Personalized audiovisual gamma stimulation enhances neural connectivity and entrainment beyond fixed 40 Hz protocols.

Frontiers in neuroscience·2026

Same author

Integrated Assessment of CT-Derived Fibrosis Volume and Pulmonary Function in Identifying Progressive Pulmonary Fibrosis in Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).

Archivos de bronconeumologia·2026

Same author

Evaluation of Clinical Characteristics and Lung Function Trajectories in Young COPD Patients Within the General Population.

International journal of chronic obstructive pulmonary disease·2026

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

Cardiomyopathy associated with clozapine.

Sungwon Roh¹, Dong Hyun Ahn, Jung Hyun Nam

¹Department of Neuropsychiatry, Hanyang University Hospital, Seoul, Korea. swroh@hmc.hanyang.ac.kr

Experimental and Clinical Psychopharmacology

|March 1, 2006

Summary

Clozapine can cause serious heart problems, including cardiomyopathy. This case report highlights the recurrence of clozapine-induced cardiomyopathy in a patient, emphasizing the need for awareness.

More Related Videos

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Related Experiment Videos

Last Updated: Jun 24, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Area of Science:

Cardiology
Psychiatry
Pharmacology

Background:

Clozapine is an effective antipsychotic for refractory schizophrenia with fewer extrapyramidal side effects.
However, clozapine carries risks of serious adverse effects, including cardiac complications and agranulocytosis.

Observation:

A 31-year-old Korean male with schizophrenia developed dilated cardiomyopathy while on clozapine treatment.
Discontinuation of clozapine led to clinical improvement, but readministration resulted in recurrent cardiomyopathy.

Findings:

This is the first reported case of clozapine-induced cardiomyopathy recurrence in East Asia.
The findings strongly support a causal relationship between clozapine and cardiac complications.

Implications:

Clinicians should be vigilant for cardiac complications, specifically cardiomyopathy, in patients treated with clozapine.
This case underscores the importance of monitoring cardiac health during clozapine therapy, especially upon re-challenge.